Esperion Therapeutics, Inc. (ESPR)
Pre-market:
| Previous close | 6.45 |
| Open | 6.37 |
| Bid | 6.17 x 1300 |
| Ask | 7.40 x 1300 |
| Day's range | 6.24 - 7.03 |
| 52-week range | 3.28 - 19.79 |
| Volume | |
| Avg. volume | 1,209,238 |
| Market cap | 440.416M |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Real World Data Analysis Reveals Nearly Half of All Adults at High Risk for ASCVD and Eligible for a Statin Were Not On Any Statin
– Less than 1 in 10 were on any non-statin lipid lowering therapy – – Findings were shared at the National Lipid Association Scientific Sessions – ANN ARBOR, Mich., June 03, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) announced findings from a real-world analysis of more than 400,000 patients at high-risk for atherosclerotic cardiovascular disease (ASCVD). The findings were presented at the National Lipid Association Scientific Sessions in Scottsdale, Arizona. “While professional guidelines
- GlobeNewswire
Esperion to Participate in the 2022 Jefferies Global Healthcare Conference
ANN ARBOR, Mich., June 02, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming 2022 Jefferies Global Healthcare Conference on June 8th, 2022. Event:2022 Jefferies Global Healthcare ConferenceDate:Wednesday, June 8th, 2022Format:Presentation and 1:1 MeetingsTime:9:00 AM (ET)Webcast:Link A live audio webcast can be accessed on the investor and media section of the Esperion website at https://www.
- GlobeNewswire
Esperion Announces the Appointment of J. Martin Carroll to its Board of Directors
ANN ARBOR, Mich., June 01, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of J. Martin Carroll as Chairperson of Esperion’s Board of Directors. Mr. Carroll will serve as a Class I director with a term expiring at the 2023 annual meeting of stockholders. "On behalf of the Esperion team and our directors, I am excited to welcome Marty as Chairperson of the Esperion Board. With his significant experience, Marty will provide additional leadership and strategic guida
